- Home
- DYN vs ATGE Comparison
DYN vs ATGE Comparison
Compare DYN & ATGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- ATGE
- Stock Information
- Founded
- DYN 1984
- ATGE 1987
- Country
- DYN United States
- ATGE United States
- Employees
- DYN N/A
- ATGE N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- ATGE Other Consumer Services
- Sector
- DYN Health Care
- ATGE Consumer Discretionary
- Exchange
- DYN Nasdaq
- ATGE Nasdaq
- Market Cap
- DYN 3.4B
- ATGE 2.7B
- IPO Year
- DYN 2020
- ATGE 1991
- Fundamental
- Price
- DYN $28.39
- ATGE $87.22
- Analyst Decision
- DYN Strong Buy
- ATGE Buy
- Analyst Count
- DYN 9
- ATGE 3
- Target Price
- DYN $52.44
- ATGE $85.00
- AVG Volume (30 Days)
- DYN 1.0M
- ATGE 465.0K
- Earning Date
- DYN 11-12-2024
- ATGE 10-29-2024
- Dividend Yield
- DYN N/A
- ATGE N/A
- EPS Growth
- DYN N/A
- ATGE 88.45
- EPS
- DYN N/A
- ATGE 4.36
- Revenue
- DYN N/A
- ATGE $1,633,207,000.00
- Revenue This Year
- DYN N/A
- ATGE $9.99
- Revenue Next Year
- DYN N/A
- ATGE $5.97
- P/E Ratio
- DYN N/A
- ATGE $20.02
- Revenue Growth
- DYN N/A
- ATGE 11.45
- 52 Week Low
- DYN $9.82
- ATGE $43.78
- 52 Week High
- DYN $47.45
- ATGE $92.93
- Technical
- Relative Strength Index (RSI)
- DYN 42.04
- ATGE 62.06
- Support Level
- DYN $27.99
- ATGE $89.15
- Resistance Level
- DYN $35.68
- ATGE $92.93
- Average True Range (ATR)
- DYN 2.09
- ATGE 4.08
- MACD
- DYN 0.23
- ATGE 0.43
- Stochastic Oscillator
- DYN 9.12
- ATGE 72.81
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.
About ATGE Adtalem Global Education Inc.
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.